RxSight (RXST) Total Current Liabilities (2020 - 2026)
RxSight's (RXST) quarterly Total Current Liabilities came in at $27.4 million in Q1 2026, up 20.38% YoY from $22.7 million in Q1 2025, and up 4.28% on a QoQ basis from $26.3 million in Q4 2025.
RxSight (RXST) Total Current Liabilities (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Total Current Liabilities data on file, last reported at $27.4 million in Q1 2026.
- Quarterly Total Current Liabilities rose 20.38% year-over-year to $27.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.4 million (up 20.38% YoY) and the FY2025 annual result came in at $26.3 million, up 1.46% from the prior year.
- Total Current Liabilities rose to $27.4 million in Q1 2026, from $26.3 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $27.4 million in Q1 2026 to a low of $10.7 million in Q1 2022.
- A 5-year average of $19.6 million and a median of $19.6 million in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities surged 78.38% — and 2025, when it slipped 1.53%.
- Tracing RXST's Total Current Liabilities over 5 years: stood at $17.2 million in 2022, then climbed by 21.27% to $20.9 million in 2023, then increased by 23.79% to $25.9 million in 2024, then rose by 1.46% to $26.3 million in 2025, then increased by 4.28% to $27.4 million in 2026.
- The last three Total Current Liabilities figures came in at $27.4 million (Q1 2026), $26.3 million (Q4 2025), and $22.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 1.28 Bn |
| 10 | RxSight | 253.72 Mn | -150.53 Mn | - | 80.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 80.44 Mn |
| Mar 31, 2026 | 27.38 Mn |
| Dec 31, 2025 | 26.25 Mn |
| Sep 30, 2025 | 22.29 Mn |
| Jun 30, 2025 | 20.38 Mn |
| Mar 31, 2025 | 22.74 Mn |
| Dec 31, 2024 | 25.88 Mn |
| Sep 30, 2024 | 22.64 Mn |
| Jun 30, 2024 | 19.62 Mn |
| Mar 31, 2024 | 18.33 Mn |
| Dec 31, 2023 | 20.90 Mn |
| Sep 30, 2023 | 18.94 Mn |
| Jun 30, 2023 | 16.57 Mn |
| Mar 31, 2023 | 14.88 Mn |
| Dec 31, 2022 | 17.24 Mn |
| Sep 30, 2022 | 16.37 Mn |
| Jun 30, 2022 | 13.00 Mn |
| Mar 31, 2022 | 10.66 Mn |
| Dec 31, 2021 | 11.08 Mn |
| Sep 30, 2021 | 9.18 Mn |